Demo Sign up Log In

Voyager Therapeutics Inc (VYGR)

Cash Conversion Ratio

1.06×

Quarterly · Period ending: Jun 30, 2026

VYGR Cash Conversion Ratio

Latest reported1.06×period endingJun 30, 2026

Latest reported1.06×period endingJun 30, 2026

VYGR Quarterly Cash Conversion Ratio (-4.42× → 1.06×)

Latest values, visible window

High-resolution chart · PNG

VYGR cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Voyager Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	1.0559×
Mar 31, 2026	1.1967×
Dec 31, 2025	1.1263×
Sep 30, 2025	1.1206×
Jun 30, 2025	1.0295×
Mar 31, 2025	1.2428×
Dec 31, 2024	0.4258×
Sep 30, 2024	3.121×
Jun 30, 2024	3.2094×
Mar 31, 2024	-4.9979×
Dec 31, 2023	-0.4347×
Sep 30, 2023	0.8429×
Jun 30, 2023	0.0921×
Mar 31, 2023	0.992×
Dec 31, 2022	0.5577×
Sep 30, 2022	-0.9353×
Jun 30, 2022	1.0335×
Mar 31, 2022	-1.613×
Dec 31, 2021	1.9002×
Sep 30, 2021	0.8501×
Jun 30, 2021	0.7618×
Mar 31, 2021	1.0009×
Dec 31, 2020	1.6032×
Sep 30, 2020	-0.3492×
Jun 30, 2020	2.659×
Mar 31, 2020	1.249×
Dec 31, 2019	2.1263×
Sep 30, 2019	1.5163×
Jun 30, 2019	-3.0145×
Mar 31, 2019	-4.566×
Dec 31, 2018	1.1038×
Sep 30, 2018	0.9116×
Jun 30, 2018	0.9329×
Mar 31, 2018	-2.3589×
Dec 31, 2017	1.2743×
Sep 30, 2017	0.6981×
Jun 30, 2017	0.8901×
Mar 31, 2017	1.0355×
Dec 31, 2016	1.1559×
Sep 30, 2016	1.1885×
Jun 30, 2016	1.0617×
Mar 31, 2016	1.3838×
Dec 31, 2015	1.3288×
Sep 30, 2015	1.7894×
Jun 30, 2015	1.9209×
Mar 31, 2015	-4.4205×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.